Multifaceted Benefit of Whole Blood Versus Lactated Ringer's Resuscitation After Traumatic Brain Injury and Hemorrhagic Shock in Mice

全血复苏与乳酸林格氏液复苏在小鼠创伤性脑损伤和出血性休克中的多方面益处

阅读:1

Abstract

BACKGROUND: Despite increasing use in hemorrhagic shock (HS), whole blood (WB) resuscitation for polytrauma with traumatic brain injury (TBI) is largely unexplored. Current TBI guidelines recommend crystalloid for prehospital resuscitation. Although WB outperforms lactated Ringer's (LR) in increasing mean arterial pressure (MAP) in TBI + HS models, effects on brain tissue oxygenation (PbtO(2)), and optimal MAP remain undefined. METHODS: C57BL/6 mice (n = 72) underwent controlled cortical impact followed by HS (MAP = 25-27 mmHg). Ipsilateral hippocampal PbtO(2) (n = 40) was measured by microelectrode. Mice were assigned to four groups (n = 18/group) for "prehospital" resuscitation (90 min) with LR or autologous WB, and target MAPs of 60 or 70 mmHg (LR(60), WB(60), LR(70), WB(70)). Additional LR (10 ml/kg) was bolused every 5 min for MAP below target. RESULTS: LR requirements in WB(60) (7.2 ± 5.0 mL/kg) and WB(70) (28.3 ± 9.6 mL/kg) were markedly lower than in LR(60) (132.8 ± 5.8 mL/kg) or LR(70) (152.2 ± 4.8 mL/kg; all p < 0.001). WB(70) MAP (72.5 ± 2.9 mmHg) was higher than LR(70) (59.8 ± 4.0 mmHg, p < 0.001). WB(60) MAP (68.7 ± 4.6 mmHg) was higher than LR(60) (53.5 ± 3.2 mmHg, p < 0.001). PbtO(2) was higher in WB(60) (43.8 ± 11.6 mmHg) vs either LR(60) (25.9 ± 13.0 mmHg, p = 0.04) or LR(70) (24.1 ± 8.1 mmHg, p = 0.001). PbtO(2) in WB(70) (40.7 ± 8.8 mmHg) was higher than in LR(70) (p = 0.007). Despite higher MAP in WB(70) vs WB(60) (p = .002), PbtO(2) was similar. CONCLUSION: WB resuscitation after TBI + HS results in robust improvements in brain oxygenation while minimizing fluid volume when compared to standard LR resuscitation. WB resuscitation may allow for a lower prehospital MAP without compromising brain oxygenation when compared to LR resuscitation. Further studies evaluating the effects of these physiologic benefits on outcome after TBI with HS are warranted, to eventually inform clinical trials.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。